Teoh LJ, Solebo AL, Rahi JS, Morton C, Allen L, McPhee D, et al. Visual impairment, severe visual impairment, and blindness in children in Britain (BCVIS2): a national observational study. Lancet Child Adolesc Health [Internet]. 2021;5:190–200.

Article  PubMed  PubMed Central  Google Scholar 

NICE health technology evaluations: the manual (PMG36). 2022.

Burton MJ, Ramke J, Marques AP, Bourne RRA, Congdon N, Jones I, et al. The Lancet Global Health Commission on global eye health: vision beyond 2020. Lancet Glob Health [Internet]. 2021;9:e489-551.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cost effectiveness of eye health treatments—The International Agency for the Prevention of Blindness [Internet]. https://www.iapb.org/learn/vision-atlas/solutions/cost-effectiveness/. Accessed 15 Dec 2021.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Revista Espanola de Nutricion Humana y Dietetica [Internet]. 2016;20:148–60. https://doi.org/10.1186/2046-4053-4-1.

Article  Google Scholar 

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:2700.

Article  Google Scholar 

Boluyt N, Tjosvold L, Lefebvre C, Klassen TP, Offringa M. Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE. Arch Pediatr Adolesc Med. 2008;162:111–6.

Article  PubMed  Google Scholar 

Veritas Health Innovation M. Covidence systematic review software [Internet]. www.covidence.org. Accessed 29 May 2020.

World Health Organization. ICD-10 : international statistical classification of diseases and related health problems : tenth revision, 2nd ed. World Health Organization. [Internet]. 2004. https://apps.who.int/iris/handle/10665/42980. Accessed 29 May 2020.

Molinier L, Bauvin E, Combescure C, Castelli C, Rebillard X, Soulié M, et al. Methodological considerations in cost of prostate cancer studies: a systematic review. Value Health. 2008;11:878–85.

Article  PubMed  Google Scholar 

Figure 15.5.a: Drummond checklist [Internet]. https://handbook-5-1.cochrane.org/chapter_15/figure_15_5_a_drummond_checklist_drummond_1996.htm. Accessed 29 May 2020.

Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ [Internet]. 2020. https://doi.org/10.1136/bmj.l6890.

Article  PubMed  PubMed Central  Google Scholar 

Prices-Inflation (CPI)—OECD Data [Internet]. https://data.oecd.org/price/inflation-cpi.htm. Accessed 25 Aug 2020.

Conversion rates—Purchasing power parities (PPP)—OECD Data [Internet]. https://data.oecd.org/conversion/purchasing-power-parities-ppp.htm. Accessed 25 Aug 2020.

Honeycutt AA, Grosse SD, Dunlap LJ, Schendel DE, Chen H, Brann E, et al. Economic costs of mental retardation, cerebral palsy, hearing loss, and vision impairment. Research in Social Science and Disability. Bingley: Emerald Group Publishing Limited; 2003. p. 207–28.

Google Scholar 

Socioeconomic impact of low vision and blindness from paediatric eye disease in Australia Save Sight Institute The University of Sydney. 2016. Report prepared by Deloitte Access Economics [Internet]. https://www.deloitte.com/au/en/services/economics/analysis/socioeconomic-impact-low-vision-blindness-paediatric-eye-disease-australia.html

Guide Dogs for the Blind Association. The costs of blindness: an analysis of the costs of visual impairment and blindness in the United Kingdom [Internet]. https://publications.parliament.uk/pa/cm200203/cmhansrd/vo031119/text/31119w67.htm. Accessed 11 November 2020.

Wittenborn J, Rein D. Cost of vision problems: the Economic Burden of Vision Loss and Eye Disorders in the United States. NORC. University of Chicago; 2013.

Zin AA, Magluta C, Pinto MF, Entringer AP, Mendes-Gomes MA, Moreira ME, et al. Retinopathy of prematurity screening and treatment cost in Brazil. Rev Panam Salud Publica [Internet]. 2014;36:37–43.

PubMed  Google Scholar 

Stillwaggon E, Carrier CS, Sautter M, McLeod R. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis. 2011;5: e1333.

Article  PubMed  PubMed Central  Google Scholar 

Noble J, Hollands H, Forooghian F, Yazdani A, Sharma S, et al. Evaluating the cost-effectiveness of anterior uveitis investigation by Canadian ophthalmologists. Can J Ophthalmol [Internet]. 2008;43:652–7.

Article  PubMed  Google Scholar 

Cernat A, Jamieson M, Kavelaars R, Khalili S, Bhambhwani V, Mireskandari K, et al. Immediate versus delayed sequential bilateral cataract surgery in children: a cost-effectiveness analysis. Br J Ophthalmol [Internet]. 2022;106:211–7.

Article  PubMed  Google Scholar 

Prusa A, Kasper DC, Sawers L, Walter E, Hayde M, Stillwaggon E. Congenital toxoplasmosis in Austria: prenatal screening for prevention is cost-saving. PLoS Negl Trop Dis [Internet]. 2017;11: e0005648.

Article  PubMed  Google Scholar 

Dave H. Simultaneous vs sequential bilateral cataract surgery for infants with congenital cataracts. Arch Ophthalmol [Internet]. 2010;128:1050. https://doi.org/10.1001/archophthalmol.2010.136.

Article  PubMed  Google Scholar 

Minden K, Niewerth M, Listing J, Möbius D, Thon A, Ganser G, et al. The economic burden of juvenile idiopathic arthritis—results from the German paediatric rheumatologic database. Clin Exp Rheumatol. 2009;27:863–9.

CAS  PubMed  Google Scholar 

Dave H, Gordillo L, Yang Z, Zhang MS, Hubbard GB, Olsen TW. The societal burden of blindness secondary to retinopathy of prematurity in Lima, Peru. Am J Ophthalmol [Internet]. 2012;154:750–5.

Article  PubMed  Google Scholar 

Korvenranta E, Lehtonen L, Rautava L, Häkkinen U, Andersson S, Gissler M, et al. Impact of very preterm birth on health care costs at five years of age. Pediatrics. 2010;125:e1109–14.

Article  PubMed  Google Scholar 

Wang J, Jin L, Lu Q, Botah RR, Ali R, Li J, et al. Barriers, costs, and attitudes toward pediatric cataract surgery at two large facilities in China and India. Ophthalmic Epidemiol [Internet]. 2019;26:47–54. https://doi.org/10.1080/09286586.2018.1513043?needAccess=true.

Article  PubMed  Google Scholar 

Anderzén-Carlsson A. CHARGE Syndrome-a five case study of the syndrome characteristics and health care consumption during the first year in life. J Pediatr Nurs [Internet]. 2015;30:6–16.

Article  PubMed  Google Scholar 

O’Connor PM, Chou S-L, Lamoureux EL, Keeffe JE. Costs of vision impairment in childhood and youth: diary case studies. Optom Vis Sci [Internet]. 2008;85:1106–9.

Article  PubMed  Google Scholar 

Wright SE, Keeffe JE, Thies LS. Direct costs of blindness in Australia. Clin Exp Ophthalmol [Internet]. 2000;28:140–2. https://doi.org/10.1046/j.1442-9071.2000.00296.x?download=true.

Article  CAS  PubMed  Google Scholar 

Rahi JS, Cable N. Severe visual impairment and blindness in children in the UK. Lancet [Internet]. 2003;362:1359–65.

Article  PubMed  Google Scholar 

Rothschild MI, Russ R, Brennan KA, Williams CJ, Berrones D, Patel B, et al. The economic model of retinopathy of prematurity (EcROP) screening and treatment: Mexico and the United States. Am J Ophthalmol [Internet]. 2016;168:110–21.

Article  PubMed  Google Scholar 

Dunbar JA, Hsu V, Christensen M, Black B, Williams P, Beauchamp G. Cost-utility analysis of screening and laser treatment of retinopathy of prematurity. J Am Assoc Pediatr Ophthalmol Strabismus. 2009;13:186–90.

Article  Google Scholar 

Roberts T, Frenkel JK. Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. J Am Vet Med Assoc. 1990;196:249–56.

CAS  PubMed  Google Scholar 

Liu D, Huang L, Mukkamala L, Khouri AS. The economic burden of childhood glaucoma. J Glaucoma [Internet]. 2016;25:790–7.

Article  PubMed  Google Scholar 

Wittenborn JS, Zhang X, Feagan CW, Crouse WL, Shrestha S, Kemper AR, et al. The economic burden of vision loss and eye disorders among the united states population younger than 40 years. Ophthalmology. 2013;120:1728–35.

Article  PubMed  Google Scholar 

Naguib MM, Soares RR, Anzures R, Kamel J, Chandrasekar EK, Rothschild M, et al. Regionally specific economic impact of screening and treating retinopathy of prematurity in middle-income societies in the Philippines. J Pediatr Ophthalmol Strabismus [Internet]. 2019;56:388–96.

Article  PubMed  Google Scholar 

Rothschild MI, Russ R, Brennan KA, Williams CJ, Berrones D, Patel B, et al. The economic model of retinopathy of prematurity (EcROP) screening and treatment: Mexico and the United States. Am J Ophthalmol. 2016;168:110–21.

Article  PubMed  Google Scholar 

Shamanna B, Dandona L, Rao GN. Economic burden of blindness in India. Indian J Ophthalmol [Internet]. 1998;46:169–72.

CAS  PubMed  Google Scholar 

Javitt J, Cas RD, Chiang YP. Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics [Internet]. 1993;91:859–66.

Article  CAS  PubMed  Google Scholar 

Korvenranta E, Lehtonen L, Rautava L, Häkkinen U, Andersson S, Gissler M, et al. Impact of very preterm birth on health care costs at five years of age. Pediatrics [Internet]. 2010;125:e1109–14.

Article  PubMed  Google Scholar 

Jackson KM, Scott KE, Zivin JG, Bateman DA, Flynn JT, Keenan JD, et al. Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management. Arch Ophthalmol [Internet]. 2008;126:493–9.

Article  PubMed  Google Scholar 

Liu D, Huang L, Mukkamala L, Khouri AS. The economic burden of childhood glaucoma. J Glaucoma. 2016;25:790–7.

Article  PubMed  Google Scholar 

Brown GC, Brown MM, Sharma S, Tasman W, Brown HC. Cost-effectiveness of treatment for threshold retinopathy of prematurity. Pediatrics [Internet]. 1999;104:e47.

Article  CAS  PubMed  Google Scholar 

Jackson KM, Scott KE, Graff Zivin J, Bateman DA, Flynn JT, Keenan JDCMF. Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management. Arch Ophthalmol [Internet]. 2008;126:4–493.

Google Scholar 

Kamholz KL, Cole CH, Gray JE, Zupancic JAF. Cost-effectiveness of early treatment for retinopathy of prematurity. Pediatrics [Internet]. 2009;123:262–9.

Article